Glenmark Pharma approves Ryaltris in Australia
Ryaltris is a new fixed‐dose combination nasal spray of an antihistamine and a steroid indicated for treatment of symptoms…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Glenmark Pharmaceuticals
Browsing Tag
Glenmark Pharmaceuticals
Glenmark receives ANDA approval for Dimethyl Fumarate Delayed-Release capsules
The drug is indicated to treat relapsing forms of multiple sclerosis
Glenmark Pharmaceuticals has been granted tentative…
US FDA issues warning letter to Glenmark for its Baddi facility
US FDA had inspected the facility between April 15 and April 20 and earlier classified the inspection as an official action…
Glenmark receives Orphan Drug Designation for GBR 1342
The drug is indicated for the treatment of multiple myeloma
Glenmark Pharmaceuticals (Glenmark), announced that the US Food and…
Glenmark receives ANDA approval for Clobetasol Propionate Foam
The drug is indicated for the treatment of plaque psoriasis
Glenmark Pharmaceuticals, USA (Glenmark) has been granted final…
Glenmark receives approval to market Remogliflozin and Metformin combination drug
The company will commercialise the product under the brand names ‘Remo-M’ and Remozen-M’
Glenmark Pharma gets US FDA nod for cholesterol lowering drug
The approved products, Ezetimibe and Simvastatin tablets in the strengths of 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80…
Glenmark Pharma says US FDA has issued CRL for Ryaltris
The CRL cites deficiencies in the Drug Master File pertaining to one of the active pharmaceutical ingredients and in manufacturing…
Glenmark to partner with Novartis to market three respiratory products in Brazil
This arrangement will strengthen Glenmark's respiratory franchise in Brazil Novartis will be responsible to manufacture the…
Glenmark Pharma gets tentative nod from US FDA for acne treatment drug
The drug, Clindamycin Phosphate Foam, 1 per cent, is a generic version of Mylan Pharmaceuticals' Evoclin Foam